Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium

被引：55

作者：

Bogaerts, Pierre

Naas, Thierry

Wybo, Ingrid

Bauraing, Caroline

Soetens, Oriane

Pierard, Denis

Nordmann, Patrice

Glupczynski, Youri

机构：

[1] Clin Univ UCL Mt Godinne, Bacteriol Lab, B-5530 Yvoir, Belgium

[2] Univ Paris 11, Fac Med Paris Sud, Assistance Publ Hop Paris, Hop Bicetre,Serv Bacteriol Virol, Le Kremlin Bicetre, France

[3] Free Univ Brussels, Akad Ziekenhuis, Dienst Microbiol & Ziekenhuishyg, B-1090 Brussels, Belgium

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2006年 / 44卷 / 11期

关键词：

D O I：

10.1128/JCM.00796-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 17 patients between September 2004 and August 2005 at the Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium. These multidrug-resistant isolates, which belonged to a single clone, remained susceptible to colistin and tigecycline only and produced the carbapenem-hydrolyzing oxacillinase OXA-58. This study highlights the importance of the intercountry spread of this P-lactamase-mediated resistance mechanism and its epidemic evolution.

引用

收藏

页码：4189 / 4192

页数：4

相关论文

共 24 条

[1] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].

Afzal-Shah, M ;

Woodford, N ;

Livermore, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588

[2] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].

BergogneBerezin, E ;

Towner, KJ .

CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+

[3] Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina [J].

Brown, S ;

Young, HK ;

Amyes, SGB .

CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) :15-23

[4] OXA β-lactamases in Acinetobacter:: the story so far [J].

Brown, S ;

Amyes, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) :1-3

[5] Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein [J].

Clark, RB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :245-251

[6]

Clinical and Laboratory Standards, 2005, PERF STAND ANT SUSC

[7] Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents [J].

Coelho, J ;

Woodford, N ;

Afzal-Shah, M ;

Livermore, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :756-758

[8] IMIPENEM RESISTANCE IN ACINETOBACTER-BAUMANNII IS DUE TO ALTERED PENICILLIN-BINDING PROTEINS [J].

GEHRLEIN, M ;

LEYING, H ;

CULLMANN, W ;

WENDT, S ;

OPFERKUCH, W .

CHEMOTHERAPY, 1991, 37 (06) :405-412

[9] Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii [J].

Héritier, C ;

Poirel, L ;

Lambert, T ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3198-3202

[10] A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58 [J].

Héritier, C ;

Dubouix, A ;

Poirel, L ;

Marty, N ;

Nordmann, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) :115-118